Loading...
XWAR
SNT
Market cap681mUSD
Jun 18, Last price  
296.40PLN
1D
1.16%
1Q
10.76%
Jan 2017
1,777.14%
IPO
3,545.76%
Name

Synektik SA

Chart & Performance

D1W1MN
XWAR:SNT chart
P/E
29.87
P/S
4.05
EPS
9.92
Div Yield, %
2.78%
Shrs. gr., 5y
Rev. gr., 5y
35.87%
Revenues
681m
+9.16%
31,026,57145,077,18261,451,51277,375,82778,693,40683,598,41749,433,13662,936,490105,323,138134,786,623125,386,200128,627,450166,860,941446,871,567624,121,793681,297,040
Net income
102m
+20.75%
1,063,660008,244,2983,604,8050388,0914,085,13010,293,4369,136,2958,810,1348,383,81010,301,20652,452,19084,636,220102,194,940
CFO
78m
-13.26%
07,150,8912,666,7686,431,59211,962,2635,722,563014,571,6405,224,43813,547,20313,927,83821,710,302094,493,46389,609,37377,728,270
Dividend
Jan 28, 202610.75 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Synektik Spólka Akcyjna, founded in 2001 and headquartered in Warsaw, Poland, operates as a comprehensive provider of products, services, and information technology solutions within the Polish market. The company focuses its offerings on the fields of surgery, diagnostic imaging, and nuclear medicine. Its core business activities include the distribution of medical equipment utilized in diagnostics, therapy, and nuclear medicine, alongside the creation of specialized IT solutions for radiology. Synektik also manufactures and supplies radiopharmaceutical products crucial for cancer diagnostics. In addition to these, it maintains a research laboratory dedicated to advancing diagnostic imaging systems and runs a service center for medical apparatus. The company further extends its services to include maintenance for medical equipment and the execution of essential acceptance and specialist tests.
IPO date
Aug 09, 2011
Employees
151
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT